Resveratrol Treatment in p25 Transgenic Mice
Objective: To assess the neuroprotective effects of resveratrol and SIRT1 activation in p25 transgenic mice, measuring neurodegeneration, learning capacity, and protein acetylation levels
This is a Resveratrol Treatment in p25 Transgenic Mice protocol using mouse as the model organism. The procedure involves 5 procedural steps, 1 equipment items, 2 materials. Extracted from a 2007 paper published in The EMBO Journal.
Model and subjects
mouse • p25 transgenic • unknown • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Resveratrol administration to p25 transgenic mice • Assess learning capacity • Measure hippocampal neurodegeneration
Primary readouts
- Neurodegeneration in hippocampus
- Learning capacity/impairment
- Acetylation levels of PGC-1alpha
- Acetylation levels of p53
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Resveratrol administration to p25 transgenic mice
Administer resveratrol to inducible p25 transgenic mice to activate SIRT1 pathway
Note: Dosage and route of administration not specified in provided text
View evidence from paper
“In the inducible p25 transgenic mouse, a model of AD and tauopathies, resveratrol reduced neurodegeneration”
Assess learning capacity
Conduct behavioral testing to measure learning impairment in treated p25 transgenic mice
Note: Specific behavioral test not detailed in provided text
View evidence from paper
“prevented learning impairment”
Measure hippocampal neurodegeneration
Evaluate neurodegeneration in the hippocampus following resveratrol treatment
Note: Specific measurement method not detailed in provided text
View evidence from paper
“resveratrol reduced neurodegeneration in the hippocampus”
Measure protein acetylation levels
Assess acetylation of SIRT1 substrates PGC-1alpha and p53 following resveratrol treatment
Note: Specific analytical method not detailed in provided text
View evidence from paper
“decreased the acetylation of the known SIRT1 substrates PGC-1alpha and p53”
SIRT1 lentivirus hippocampal injection
Inject SIRT1 lentivirus directly into the hippocampus of p25 transgenic mice as alternative intervention
Note: Injection volume, coordinates, and viral titer not specified in provided text
View evidence from paper
“injection of SIRT1 lentivirus in the hippocampus of p25 transgenic mice conferred significant protection against neurodegeneration”